METTL3, an Independent Adverse Prognostic Factor for AML, Promotes the Development of AML by Modulating the

Yuqian Tang1, Xiaoyan Liu1,2, Wu Ye1

  • 1Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Cancer Medicine
|April 2, 2025
PubMed
Abstract

Insights

The m6A RNA-modifying enzyme METTL3 is linked to poor prognosis in acute myeloid leukemia (AML). METTL3 influences the PGC-1α oncogene, impacting MAPK signaling and antioxidant systems in AML progression.

Area of Science:

  • Epigenetics
  • Molecular Biology
  • Oncology

Background:

  • m6A is a key mRNA modification in mammals.
  • m6A enzymes are implicated in acute myeloid leukemia (AML) but their clinical relevance and mechanisms are unclear.

Purpose of the Study:

  • To define the clinical relevance of m6A RNA-modifying enzymes in AML.
  • To elucidate the mechanisms by which these enzymes modulate AML.

Main Methods:

  • Quantified expression of METTL3, METTL14, WTAP, FTO, and ALKBH5 in AML patients.
  • Performed METTL3 and PGC-1α knockdown experiments in AML cell lines (K562, MV4-11).
  • Analyzed MAPK signaling pathway and antioxidant system gene expression.
  • Correlated PGC-1α and METTL3 mRNA levels with patient prognosis using TCGA and GSE13159 datasets.

Main Results:

  • Elevated expression of m6A enzymes, including METTL3, was observed in AML patients.
  • METTL3 expression correlated with DNMT3A mutations and predicted poor prognosis.
  • METTL3 knockdown decreased m6A levels of PGC-1α, a mitochondrial oxidative stress gene.
  • PGC-1α knockdown affected MAPK signaling and antioxidant genes, and high PGC-1α expression indicated poor prognosis.

Conclusions:

  • METTL3 is an independent prognostic factor for poor outcomes in AML.
  • METTL3 regulates PGC-1α expression via m6A modification.
  • PGC-1α functions as an oncogene in AML by influencing the MAPK pathway and antioxidant system.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.2K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.0K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.1K